NVS

Q: What is the price of Novartis (NVS) today?

The current price of Novartis (NVS) is $ 153.41. The stock began the year trading around $ 137.87 and is currently priced at $ 153.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of March, totalizando US$ 3.10. O Dividend Yield referente aos 12 últimos meses é de 2.12%.

Q: Is Novartis (NVS) a good investment?

Novartis (NVS) is currently trading at $ 153.41 with a P/E ratio of 20.68. This represents a 2,725% premium compared to its historical average P/E. Over the past year, the stock paid $ 3.10 in dividends, resulting in a dividend yield of 2.12%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Novartis AG

Price

$ 153.41

return (12m)

p/e

20.68

p/bv

7.19

DIVIDEND YIELD

2.12%

NVS price

Novartis

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NVS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NVS

review the fundamentals of Novartis shares

P/E

20.68

Sector: -2.06 Industry: 0.33

P/Receita (PSR)

4.95

Sector: 1.92 Industry: 2.39

P/BV

7.19

Sector: 2.15 Industry: 2.33

Dividend Yield (DY)

2.12%

Sector: - Industry: -

Payout

43.84%

Sector: - Industry: -

Net Profit Margins

23.92%

Sector: -28.27% Industry: -31.46%

Gross Margin

75.38%

Sector: 44.63% Industry: 50.66%

Margem Operacional

30.43%

Sector: -23.33% Industry: -27.95%

Margem EBIT

30.92%

Sector: - Industry: -

Margem EBITDA

40.00%

Sector: - Industry: -

EV/EBITDA

57.37

Sector: - Industry: -

EV/EBIT

74.21

Sector: - Industry: -

EV/EBITDA

12.49

Sector: -0.50 Industry: 1.01

EV/EBIT

16.46

Sector: -1.98 Industry: -0.27

P/Ativo

2.36

Sector: 1.16 Industry: 1.20

P/Cap Giro

-58.71

Sector: - Industry: -

P/Ativo Circ Líq

-5.28

Sector: - Industry: -

BVPS

20.39

Sector: 3.80 Industry: 4.82

EPS

7.09

Sector: -0.90 Industry: -0.85

Giro de Ativos

0.11

Sector: - Industry: -

ROE

34.77%

Sector: -30.04% Industry: -35.35%

ROIC

12.93%

Sector: -416.85% Industry: -76.64%

ROA

11.42%

Sector: -26.18% Industry: -25.13%

Dívida Líquida / Patrimônio

0.78

Sector: - Industry: -

Dívida Líquida / EBITDA

5.63

Sector: - Industry: -

Dívida Líquida / EBIT

7.29

Sector: - Industry: -

Dívida Bruta / Patrimônio

0.96

Sector: - Industry: -

Patrimônio / Ativos

0.33

Sector: 0.44 Industry: 0.45

Passivos / Ativos

0.67

Sector: 0.47 Industry: 0.50

Liquidez Corrente

0.85

Sector: - Industry: -

CAGR Receitas 5 Anos

1.36%

Sector: - Industry: -

CAGR Lucros 5 Anos

-10.84%

Sector: - Industry: -

FAIR VALUE OF Novartis ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$153.41

Fair Value

$57.03

Upside/Downside Return potential.

-62.82%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NVS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
EW	44.50	0.00	0.00%	0.00%	$48.62 B	17.34%
BSX	23.54	0.00	0.00%	0.00%	$83.90 B	17.29%
ABT	25.14	0.00	0.00%	2.64%	$157.79 B	13.91%
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
ALGN	29.07	3.01	10.36%	0.00%	$12.50 B	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NVS Historical Dividends

current DY: 2.12%

5-year average DY: 4.01%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/11/2026	03/16/2026	3.10240000
Dividends	03/12/2025	04/25/2025	3.86950000
Dividends	03/08/2024	04/19/2024	3.77700000
Dividends	03/10/2023	03/20/2023	3.46900000
Dividends	03/09/2022	03/17/2022	3.32530000
Dividends	03/05/2021	03/15/2021	3.37800000
Dividends	03/04/2020	03/12/2020	3.04200000
Dividends	03/05/2019	03/13/2019	2.86500000
Dividends	03/07/2018	04/25/2018	2.97700000
Dividends	03/03/2017	04/20/2017	2.74600000
Dividends	02/26/2016	04/15/2016	2.76200000
Dividends	03/04/2015	04/20/2015	2.81700000
Dividends	03/03/2014	04/10/2014	2.71900000
Dividends	02/28/2013	04/05/2013	2.53000000
Dividends	02/29/2012	04/05/2012	2.46000000
Dividends	02/28/2011	04/08/2011	2.35300000
Dividends	03/04/2010	04/13/2010	1.98700000
Dividends	02/26/2009	04/06/2009	1.72000000
Dividends	02/28/2008	04/11/2008	1.47200000
Dividends	03/08/2007	04/10/2007	1.08100000
Dividends	03/02/2006	04/03/2006	0.89400000
Dividends	03/03/2005	04/06/2005	0.98570000
Dividends	02/26/2004	03/30/2004	0.80600000
Dividends	03/06/2003	04/07/2003	0.70000000
Dividends	03/25/2002	04/22/2002	0.52200000
Dividends	03/26/2001	04/20/2001	0.50200000

ABOUT Novartis

Novartis AG

Average Investor10 user rating

4.0 (0 people)

States of America

30 years

Founded: 1996

1996

Time since IPO - 30 years

105.794

Employees

Novartis AG (States of America) is listed on the NYSE and has a market capitalization of $279.88 billion, with shareholders equity totaling $38.93 billion.

The company employs approximately 105.794 people and operates in the Saúde sector, within the Principais Medicamentos industry.

Over the past 12 months, Novartis AG reported $56.58 billion in revenue, generating net income of $13.53 billion.

Key financial metrics include a P/E ratio of 20.68, a price-to-book (P/B) ratio of 7.19, and a trailing twelve-month dividend yield of 2.12%.

The company trades under the ticker NVS.

Market cap

$279.88 billion

Net worth

$38.93 billion

$ 38,927,000,000.00

Assets

$118.53 billion

$ 118,532,000,000.00

Total Shares Outstanding

1.91 billion

1,909,000,000

Average Daily Trading Volume

$2.08 million

$ 2,077,281.64

Sector

Saúde

Industry

Principais Medicamentos

NVS

revenue by Business Segment Novartis

NVS revenue and profits

Financial Results NVS

DRAG THE FRAME TO SEE MORE DATA

NVS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$77.63 27,53% (12M)

P/E

58.97

3.24%

ROE

2.35%

P/BV

1.38

CI - Cigna

$272.65 --10,48% (12M)

P/E

10.33

2.15%

ROE

16.97%

P/BV

1.75

CNC - Centene

$37.26 --32,06% (12M)

P/E

-4.07

0.00%

ROE

-29.93%

P/BV

1.22

HUM - Humana

$196.30 --12,22% (12M)

P/E

24.81

1.52%

ROE

6.06%

P/BV

1.50

LLY - Eli Lilly

$923.03 20,77% (12M)

P/E

34.11

0.65%

ROE

81.01%

P/BV

27.64

HCA - HCA Healthcare

$498.78 31,64% (12M)

P/E

14.28

0.68%

ROE

-228.14%

P/BV

-32.58

ABT - Abbott

$101.06 --23,01% (12M)

P/E

25.14

2.64%

ROE

0.00%

P/BV

0.00

LBPSW - 4D pharma

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$77.63 27,53% (12 M)

P/L

58.97

3.24%

ROE

2.35%

P/VP

1.38

CI - Cigna

$272.65 --10,48% (12 M)

P/L

10.33

2.15%

ROE

16.97%

P/VP

1.75

CNC - Centene

$37.26 --32,06% (12 M)

P/L

-4.07

0.00%

ROE

-29.93%

P/VP

1.22

HUM - Humana

$196.30 --12,22% (12 M)

P/L

24.81

1.52%

ROE

6.06%

P/VP

1.50

LLY - Eli Lilly

$923.03 20,77% (12 M)

P/L

34.11

0.65%

ROE

81.01%

P/VP

27.64

HCA - HCA Healthcare

$498.78 31,64% (12 M)

P/L

14.28

0.68%

ROE

-228.14%

P/VP

-32.58

ABT - Abbott

$101.06 --23,01% (12 M)

P/L

25.14

2.64%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of Novartis (NVS) today?

The current price of Novartis (NVS) is $ 153.41. The stock began the year trading around $ 137.87 and is currently priced at $ 153.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Novartis (NVS) pay dividends?

In the last year, Novartis (NVS) distributed dividends in the month of March, totalizando US$ 3.10. O Dividend Yield referente aos 12 últimos meses é de 2.12%.

Is Novartis (NVS) a good investment?

Novartis (NVS) is currently trading at $ 153.41 with a P/E ratio of 20.68. This represents a 2,725% premium compared to its historical average P/E. Over the past year, the stock paid $ 3.10 in dividends, resulting in a dividend yield of 2.12%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Novartis (NVS) stock?

You can buy Novartis (NVS) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NVS and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Novartis (NVS) yield today?

Over the past month, Novartis (NVS) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 3.10 per share in dividends, resulting in a dividend yield of 2.12%.

If you were to purchase 100 shares of Novartis (NVS) today at the current price of $ 153.41 your total investment would be $ 15,340.50.

Based on historical performance, the investment would have grown to approximately:

$ 15,340.50 after 1 year
$ 15,340.50 after 5 years
$ 15,340.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NVS

Novartis AG

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NVS

review the fundamentals of Novartis shares

P/E

P/Receita (PSR)

P/BV

Dividend Yield (DY)

Payout

Net Profit Margins

Gross Margin

Margem Operacional

Margem EBIT

Margem EBITDA

EV/EBITDA

EV/EBIT

EV/EBITDA

EV/EBIT

P/Ativo

P/Cap Giro

P/Ativo Circ Líq

BVPS

EPS

Giro de Ativos

ROE

ROIC

ROA

Dívida Líquida / Patrimônio

Dívida Líquida / EBITDA

Dívida Líquida / EBIT

Dívida Bruta / Patrimônio

Patrimônio / Ativos

Passivos / Ativos

Liquidez Corrente

CAGR Receitas 5 Anos

CAGR Lucros 5 Anos

Graham's Fair Value

current DY: 2.12%

5-year average DY: 4.01%

type

Ex - Dividend Date

payment date

value

Novartis AG

States of America

30 years

1996

105.794

PROFIT X PRICE NVS

Financial Results NVS

NVS cash flow

Asset, Revenue and Profit Growth - NVS

NVS balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

LLY - Eli Lilly

HCA - HCA Healthcare

ABT - Abbott

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

LLY - Eli Lilly

HCA - HCA Healthcare

ABT - Abbott

Frequently Asked Questions